NCT07463521 2026-03-17
MyVision
UCB Pharma
Phase 3 Not yet recruiting
Clinical Trials
10 trialsNCT07465289 2026-03-11
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
UCB Pharma
Phase 3 Not yet recruiting
NCT07304154 2026-03-10
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Gilead Sciences
Phase 1 Not yet recruiting
NCT07298928 2026-03-06
A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis
The Children's Hospital of Zhejiang University School of Medicine
Phase NA Not yet recruiting
NCT07221838 2026-03-03
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4 Not yet recruiting
NCT07392528 2026-02-11
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07033559 2026-01-28
Detecting Fatigue From Voice in Generalised Myasthenia Gravis
Thymia Limited
Not yet recruiting
NCT07333196 2026-01-21
Tongji NADs Cohort
Tongji Hospital
Not yet recruiting
NCT07337395 2026-01-13
PROMPT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT07323316 2026-01-07
HARMONY 360
Ad scientiam
Phase NA Not yet recruiting